VITALITY 2
Report
- Report Number
- 2124215-2013-09168
- Event Type
- Injury
- Date Received
- July 9, 2013
- Date of Event
- May 13, 2013
- Report Date
- June 6, 2013
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A REVIEW OF DEVICE MEMORY REVEALED THAT THE DEVICE DECLARED ELECTIVE REPLACEMENT INDICATOR (ERI) AFTER EXPERIENCING TWO CONSECUTIVE CHARGE TIMES GREATER THAN THE EXTENDED MID-LIFE ERI CHARGE TIME LIMIT. THE OBSERVED RATE OF BATTERY USAGE WAS COMPARED TO THE EXPECTED RATE OF BATTERY USAGE; THE RESULTS INDICATED THAT THE MONITORING VOLTAGE WAS NORMAL. THE DEVICE AND BATTERY BEHAVIOR MATCH THAT OF TRENDED UNITS THAT REACH ERI/EOL PREMATURELY DUE TO A HIGHER THAN EXPECTED CELL IMPEDANCE INCREASE.
WHEN THE DEVICE HAS BEEN REMOVED AND RECEIVED AT THE POST MARKET QUALITY ASSURANCE LABORATORY, ANALYSIS WILL BE PROVIDED AND THIS EVENT WILL BE UPDATED.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS DEVICE REPORTED THEIR DEVICE BEEPING. DURING A FOLLOW UP VISIT, INTERROGATION REVEALED ELECTIVE REPLACEMENT INDICATOR (ERI) HAD BEEN REACHED EARLIER THAN EXPECTED. A REPLACEMENT PROCEDURE IS INTENDED. UPON REMOVAL, THE DEVICE WILL BE RETURNED FOR ANALYSIS. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 312049 | VITALITY 2 | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | T167 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| L| R |